Author details

Full Name

Ogan D Abaan

Affiliation

Illumina Inc.

ORCID

Career Start Year

2005

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
34504346	Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.	Nat Biotechnol	2021
34504347	Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.	Nat Biotechnol	2021
34504346	Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.	Nat Biotechnol	2021
34504347	Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.	Nat Biotechnol	2021
26191074	miR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1.	Front Genet	2015
26191074	miR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1.	Front Genet	2015
24241536	High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias.	Nat Genet	2014
24355542	Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel.	DNA Repair (Amst)	2014
24241536	High prevalence of MAP2K1 mutations in variant and IGHV4-34-expressing hairy-cell leukemias.	Nat Genet	2014
25032700	NCI-60 whole exome sequencing and pharmacological CellMiner analyses.	PLoS One	2014
25032700	NCI-60 whole exome sequencing and pharmacological CellMiner analyses.	PLoS One	2014
24355542	Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel.	DNA Repair (Amst)	2014
23018179	Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.	Exp Cell Res	2013
23018179	Valosin containing protein (VCP/p97) is a novel substrate for the protein tyrosine phosphatase PTPL1.	Exp Cell Res	2013
23856246	The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.	Cancer Res	2013
24491168	104th American Association For Cancer Research (AACR) annual meeting; breakthroughs in science and technology changing cancer care.	ACS Chem Biol	2013
24491168	104th American Association For Cancer Research (AACR) annual meeting; breakthroughs in science and technology changing cancer care.	ACS Chem Biol	2013
23856246	The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology.	Cancer Res	2013
21765476	CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.	Oncogene	2012
21765476	CHEK2 genomic and proteomic analyses reveal genetic inactivation or endogenous activation across the 60 cell lines of the US National Cancer Institute.	Oncogene	2012
19235593	Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients.	Cancer Invest	2009
19584866	A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma.	Nat Med	2009
19235593	Multidrug resistance mediated by MRP1 gene overexpression in breast cancer patients.	Cancer Invest	2009
19189974	GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.	J Biol Chem	2009
19584866	A small molecule blocking oncogenic protein EWS-FLI1 interaction with RNA helicase A inhibits growth of Ewing's sarcoma.	Nat Med	2009
19189974	GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein.	J Biol Chem	2009
18265946	PTPL1: a large phosphatase with a split personality.	Cancer Metastasis Rev	2008
18265946	PTPL1: a large phosphatase with a split personality.	Cancer Metastasis Rev	2008
16740692	Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.	Cancer Res	2006
16740692	Oncoprotein EWS-FLI1 activity is enhanced by RNA helicase A.	Cancer Res	2006
15782144	PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.	Oncogene	2005
15782144	PTPL1 is a direct transcriptional target of EWS-FLI1 and modulates Ewing's Sarcoma tumorigenesis.	Oncogene	2005

1 - 32 of 32

Cristina Ivan

The University of Texas MD Anderson Cancer Center

Career Start Year 2010

Number of shared co-authors 1

Frederick S Vizeacoumar

College of Medicine, University of Saskatchewan

Career Start Year 2010

Number of shared co-authors 0

Thomas G P Gr??newald

German Cancer Research Center

Career Start Year 2006

Number of shared co-authors 4

Silvano Piazza

International Centre for Genetic Engineering and Biotechnology

Career Start Year 2004

Number of shared co-authors 1

Lixia Diao

The University of Texas MD Anderson Cancer Center

Career Start Year 2003

Number of shared co-authors 0

Aik Choon Tan

Huntsman Cancer Institute, The University of Utah

Career Start Year 2003

Number of shared co-authors 0

Anupama E Gururaj

National Institute of Allergy and Infectious Disease, National Institutes of Health

Career Start Year 2002

Number of shared co-authors 0

Sooryanarayana Varambally

University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center

Career Start Year 2001

Number of shared co-authors 0

Darran P O'Connor

UCD Conway Institute, University College Dublin

Career Start Year 2001

Number of shared co-authors 0

Oscar M Tirado

Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)/CIBERONC

Career Start Year 2000

Number of shared co-authors 3

Tobias Sj??blom

Uppsala University

Career Start Year 1999

Number of shared co-authors 1

Jun Yao

The University of Texas MD Anderson Cancer Center

Career Start Year 1997

Number of shared co-authors 1

Hai Hu

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Career Start Year 1996

Number of shared co-authors 0

Peter S Hammerman

Novartis Institutes for BioMedical Research

Career Start Year 1996

Number of shared co-authors 0

Tatsuhiro Shibata

Kurume University School of Medicine

Career Start Year 1993

Number of shared co-authors 4

Enrique de Alava

Servicio de Anatomia Patologica. Hospital Universitario Virgen del Rocio.

Career Start Year 1992

Number of shared co-authors 3

Phillip A Futreal

The University of Texas MD Anderson Cancer Center

Career Start Year 1991

Number of shared co-authors 2

Ben Ho Park

Vanderbilt University Medical Center

Career Start Year 1990

Number of shared co-authors 6

Todd R Golub

Broad Institute of MIT and Harvard

Career Start Year 1989

Number of shared co-authors 2

E Alejandro Sweet-Cordero

University of California San Francisco

Career Start Year 1989

Number of shared co-authors 3

Wei Zhang

The University of Texas MD Anderson Cancer Center

Career Start Year 1988

Number of shared co-authors 0

Patrick Kwok-Shing Ng

The University of Texas MD Anderson Cancer Center

Career Start Year 1987

Number of shared co-authors 0

William C Hahn

Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute

Career Start Year 1987

Number of shared co-authors 1

Rakesh Kumar

Rutgers New Jersey Medical School

Career Start Year 1987

Number of shared co-authors 0

Marc Ladanyi

Memorial Sloan Kettering Cancer Center

Career Start Year 1984

Number of shared co-authors 6

Andrew D Cherniack

Dana-Farber Cancer Institute

Career Start Year 1984

Number of shared co-authors 0

Matthew Meyerson

Broad Institute

Career Start Year 1983

Number of shared co-authors 1

Edison T Liu

USA The Jackson Laboratory Cancer Center

Career Start Year 1982

Number of shared co-authors 4

Francisca Vazquez

Broad Institute of MIT and Harvard

Career Start Year 1979

Number of shared co-authors 0

Gordon B Mills

Knight Cancer Institute, Oregon Health and Sciences University

Career Start Year 1976

Number of shared co-authors 0

row(s) 1 - 30 of 30

Jeffrey A Toretsky

Georgetown University Medical Center, Georgetown University

Co-authored papers 6

Paul S Meltzer

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 6

Aykut Uren

Georgetown University Medical Center

Co-authored papers 5

Yves Pommier

Center for Cancer Research, National Cancer Institute

Co-authored papers 4

Susan R Davis

Co-authored papers 4

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Co-authored papers 4

Robert L Walker

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Co-authored papers 3

James H Doroshow

National Cancer Institute, National Institutes of Health

Co-authored papers 3

Hayriye V Erkizan

Co-authored papers 3

William C Reinhold

Center for Cancer Research, National Cancer Institute

Co-authored papers 3